Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    MBMark Bustoros
    PMID: 32442065PMCID: PMC7367550DOIFirst author173 citations
  2. 2
    Nature communications · 2022
    MBMark Bustoros
    PMID: 35705541PMCID: PMC9200804DOIFirst author34 citations
  3. 3
    Blood advances · 2024
    MMMateo Mejia SaldarriagaJFJoshua FeinRNRoger N PearseGGGiorgio Ga. Inghirami+1 more →MBMark Bustoros
    PMID: 38776397PMCID: PMC11321283DOISenior author36 citations

Publications

37 publications

Funding

3 grants

Active

2 grants
  • MPI
    Identifying Mechanisms of Response, Resistance and Toxicity to BCMA CAR T Therapy in Multiple Myeloma
    The Asco Cancer Foundation · 2025–2026
    ASCO 244165-01
  • PI
    Characterizing the Role and Targeting of the histone methyltransferase Setd2 in Multiple Myeloma
    International Myeloma Foundation · 2024–2025
    IMF 233969-01
Completed grants (1)
  • MPI
    Characterization of the genomic and transcriptional landscape and role of tumor immune environment in multiple myeloma with extramedullary disease
    Conquer Cancer Foundation of the American Society of Clinical Oncology · 2022–2024
    ASCO 221200-01

News mentions

1 mentionView all WCM news ↗
  • Blood Test May Guide Use of Multiple Myeloma Immunotherapy
    July 24, 2024

    A simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new research.

Mentoring

1 mentee

External relationships

Advisory/Scientific Board Member

Janssen Pharmaceutical Company

Other Interest

Janssen Pharmaceutical Company

Other

Bristol-Myers Squibb Company · Menarini Silicon Biosystem